Literature DB >> 25080548

Cerebral venous thrombosis presenting with subdural haematoma as first presentation for systemic lupus erythematosus with negative antiphospholipid antibodies.

Ayman Alboudi1, Pournamy Sarathchandran1, Suhail Alrukn1, Abubaker Al Madani1.   

Abstract

We report the case of a 30-year-old woman, without any previous comorbidities presenting with acute onset headache, altered sensorium and unsteadiness of gait. Neurological evaluation revealed a drowsy patient with papilloedema, bilateral lateral rectus palsy, generalised hyper-reflexia and up going plantar responses. Urgent imaging performed showed extensive cortical venous sinus thrombosis. Workup for secondary causes of cortical venous sinus thrombosis revealed very high titres of antinuclear antibody and anti-dsDNA, but negative antiphospholipid antibodies (APLA). In hospital she started developing other complications of systemic lupus erythematosus (SLE). Urine evaluation revealed proteinuria and granular casts suggestive of glomerulonephritis. Cardiac evaluation revealed moderate pericardial effusion. We have discussed neurolupus as initial presentation of SLE and the rare occurrence of major neurovascular complications without secondary APLA syndrome. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25080548      PMCID: PMC4120032          DOI: 10.1136/bcr-2014-205355

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Cerebral vein and dural sinus thrombosis in Portugal: 1980-1998.

Authors:  J M Ferro; M Correia; C Pontes; M V Baptista; F Pita
Journal:  Cerebrovasc Dis       Date:  2001       Impact factor: 2.762

2.  Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus.

Authors:  Jamal Mikdashi; Barry Handwerger; Patricia Langenberg; Michael Miller; Steven Kittner
Journal:  Stroke       Date:  2007-01-11       Impact factor: 7.914

3.  Superior sagittal sinus thrombosis and systemic lupus erythematosus.

Authors:  Z Shiozawa; M Yoshida; K Kobayashi; S Tsunoda; T Mano
Journal:  Ann Neurol       Date:  1986-08       Impact factor: 10.422

Review 4.  Anti-phospholipid antibodies.

Authors:  E N Harris; A E Gharavi; G R Hughes
Journal:  Clin Rheum Dis       Date:  1985-12

5.  Cerebral venous thrombosis in systemic lupus erythematosus.

Authors:  M Vidailhet; J C Piette; B Wechsler; M G Bousser; P Brunet
Journal:  Stroke       Date:  1990-08       Impact factor: 7.914

Review 6.  [Cerebral venous thrombosis in systemic lupus erythematosus. Case report and literature review].

Authors:  Gladys Patricia Agreda-Vásquez; María Eugenia Galván-Plata; Haiko Nellen-Hummel; José Halabe-Cherem
Journal:  Rev Med Inst Mex Seguro Soc       Date:  2006 Jul-Aug

7.  The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.

Authors:  P A Merkel; Y Chang; S S Pierangeli; K Convery; E N Harris; R P Polisson
Journal:  Am J Med       Date:  1996-12       Impact factor: 4.965

8.  [Cerebral venous thrombosis as the presenting symptom of systemic lupus erythematosus].

Authors:  P Cardona-Portela; C Casasnovas-Pons; M Moral-Torres; F Rubio-Borrego
Journal:  Rev Neurol       Date:  2004 Jul 1-15       Impact factor: 0.870

9.  Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.

Authors:  P Thiagarajan; S S Shapiro; L De Marco
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

10.  IgG binding to endothelial cells in systemic lupus erythematosus.

Authors:  G Le Roux; M P Wautier; L Guillevin; J L Wautier
Journal:  Thromb Haemost       Date:  1986-10-21       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.